medmix AG
medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through Healthcare; and Consumer and Industrial segments. The company offers dental products, including mixing tips and cartridges for various applications, such as prosthetics, restorations, anesthetics, and aesthetics; drug delivery devices that are used to inject fertility… Read more
medmix AG (MDMXF) - Net Assets
Latest net assets as of June 2025: $430.40 Million USD
Based on the latest financial reports, medmix AG (MDMXF) has net assets worth $430.40 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($952.60 Million) and total liabilities ($522.20 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $430.40 Million |
| % of Total Assets | 45.18% |
| Annual Growth Rate | 7.59% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 28.54 |
medmix AG - Net Assets Trend (2020–2024)
This chart illustrates how medmix AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for medmix AG (2020–2024)
The table below shows the annual net assets of medmix AG from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $446.70 Million | -5.84% |
| 2023-12-31 | $474.40 Million | -6.02% |
| 2022-12-31 | $504.80 Million | -5.45% |
| 2021-12-31 | $533.90 Million | +60.14% |
| 2020-12-31 | $333.40 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to medmix AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 49890000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $498.90 Million | 114.32% |
| Total Equity | $436.40 Million | 100.00% |
medmix AG Competitors by Market Cap
The table below lists competitors of medmix AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NEURONES SA NOM. EO 040
F:NE9
|
$418.25 Million |
|
Raisio plc
F:RATV
|
$418.44 Million |
|
Motic Xiamen Electric Group Co Ltd
SHE:300341
|
$418.47 Million |
|
Changsha DIALINE New Material Sci & Tech Co Ltd
SHE:300700
|
$418.57 Million |
|
TTW Public Company Limited
PINK:TTAPF
|
$418.18 Million |
|
Zhewen Pictures Group Co Ltd
SHG:601599
|
$418.14 Million |
|
AirAsia Group Berhad
PINK:AIABF
|
$418.10 Million |
|
Shenyang Blue Silver Ind Auto
SHE:300293
|
$418.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in medmix AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 465,400,000 to 436,400,000, a change of -29,000,000 (-6.2%).
- Net loss of 7,400,000 reduced equity.
- Dividend payments of 15,000,000 reduced retained earnings.
- Share repurchases of 500,000 reduced equity.
- Other factors decreased equity by 6,100,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-7.40 Million | -1.7% |
| Dividends Paid | $15.00 Million | -3.44% |
| Share Repurchases | $500.00K | -0.11% |
| Other Changes | $-6.10 Million | -1.4% |
| Total Change | $- | -6.23% |
Book Value vs Market Value Analysis
This analysis compares medmix AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.63x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.15x to 1.63x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $8.08 | $17.40 | x |
| 2021-12-31 | $12.99 | $17.40 | x |
| 2022-12-31 | $12.34 | $17.40 | x |
| 2023-12-31 | $11.41 | $17.40 | x |
| 2024-12-31 | $10.70 | $17.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently medmix AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.70%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1.53%
- • Asset Turnover: 0.51x
- • Equity Multiplier: 2.19x
- Recent ROE (-1.70%) is below the historical average (2.36%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 2.88% | 2.73% | 0.44x | 2.38x | $-23.74 Million |
| 2021 | 8.24% | 9.62% | 0.47x | 1.83x | $-9.39 Million |
| 2022 | 2.30% | 2.43% | 0.43x | 2.19x | $-38.88 Million |
| 2023 | 0.06% | 0.06% | 0.48x | 2.16x | $-46.24 Million |
| 2024 | -1.70% | -1.53% | 0.51x | 2.19x | $-51.04 Million |
Industry Comparison
This section compares medmix AG's net assets metrics with peer companies in the Specialty Industrial Machinery industry.
Industry Context
- Industry: Specialty Industrial Machinery
- Average net assets among peers: $49,834,203,139
- Average return on equity (ROE) among peers: -24.25%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| medmix AG (MDMXF) | $430.40 Million | 2.88% | 1.21x | $418.22 Million |
| American Commerce Solutions Inc (AACS) | $554.04K | -209.75% | 2.35x | $38.47K |
| ATI Airtest Technologies Inc (AATGF) | $-3.05 Million | 0.00% | 0.00x | $2.79 Million |
| ABB Turbo Systems AG (ACLIF) | $302.90 Million | 33.41% | 2.98x | $4.32 Billion |
| Agfa-Gevaert NV (AFGVF) | $130.00 Million | -40.77% | 16.65x | $91.17 Million |
| Alphaform AG (AFRMF) | $9.59 Million | -32.38% | 1.09x | $691.72 |
| Airtificial Intelligence Structures S.A (AITLF) | $-8.71 Million | 0.00% | 0.00x | $53.18 Million |
| Alfa Laval AB (publ) (ALFVF) | $10.49 Billion | 35.97% | 1.77x | $13.09 Billion |
| Amada Co. Ltd (AMDLY) | $484.04 Billion | 5.74% | 0.27x | $3.72 Billion |
| Ametek Inc (AME) | $3.25 Billion | 18.15% | 1.05x | $49.22 Billion |
| American Superconductor Corporation (AMSC) | $125.12 Million | -52.85% | 0.73x | $1.42 Billion |